CL2008000866A1 - Uso monofasico de una composicion farmaceutica que comprende 17 beta estradiol y acetato de nomegestrol para la anticoncepcion. - Google Patents

Uso monofasico de una composicion farmaceutica que comprende 17 beta estradiol y acetato de nomegestrol para la anticoncepcion.

Info

Publication number
CL2008000866A1
CL2008000866A1 CL200800866A CL2008000866A CL2008000866A1 CL 2008000866 A1 CL2008000866 A1 CL 2008000866A1 CL 200800866 A CL200800866 A CL 200800866A CL 2008000866 A CL2008000866 A CL 2008000866A CL 2008000866 A1 CL2008000866 A1 CL 2008000866A1
Authority
CL
Chile
Prior art keywords
conception
pharmaceutical composition
single phase
nomegestrol acetate
beta estradiol
Prior art date
Application number
CL200800866A
Other languages
English (en)
Inventor
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of CL2008000866A1 publication Critical patent/CL2008000866A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CL200800866A 2007-03-26 2008-03-26 Uso monofasico de una composicion farmaceutica que comprende 17 beta estradiol y acetato de nomegestrol para la anticoncepcion. CL2008000866A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92032607P 2007-03-26 2007-03-26

Publications (1)

Publication Number Publication Date
CL2008000866A1 true CL2008000866A1 (es) 2008-10-03

Family

ID=39672648

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800866A CL2008000866A1 (es) 2007-03-26 2008-03-26 Uso monofasico de una composicion farmaceutica que comprende 17 beta estradiol y acetato de nomegestrol para la anticoncepcion.

Country Status (10)

Country Link
US (1) US20080242650A1 (es)
AR (1) AR065816A1 (es)
AU (1) AU2008231744A1 (es)
BR (1) BRPI0809089A2 (es)
CA (1) CA2682049A1 (es)
CL (1) CL2008000866A1 (es)
MX (1) MX2009010320A (es)
PE (1) PE20081895A1 (es)
TW (1) TWI472332B (es)
WO (1) WO2008116873A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
CA2740002C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
US9198920B2 (en) 2009-03-27 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
JPS61243059A (ja) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5674863A (en) * 1991-10-18 1997-10-07 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2004048326A1 (ja) * 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. ４−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤

Also Published As

Publication number Publication date
BRPI0809089A2 (pt) 2014-09-09
TW200902031A (en) 2009-01-16
CA2682049A1 (en) 2008-10-02
MX2009010320A (es) 2010-01-20
AR065816A1 (es) 2009-07-01
PE20081895A1 (es) 2009-01-26
AU2008231744A1 (en) 2008-10-02
TWI472332B (zh) 2015-02-11
WO2008116873A1 (en) 2008-10-02
US20080242650A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
CL2008000866A1 (es) Uso monofasico de una composicion farmaceutica que comprende 17 beta estradiol y acetato de nomegestrol para la anticoncepcion.
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
CL2008001002A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008000022A1 (es) Compuestos derivados de fenil-(4-fenil pirimidin-2-il)-aminas; composicion farmaceutica que comprende a dichos compuestos ; procedimiento de preparacion de dichos compuestos; y su uso en enfermedades inflamatorias, diabetes y cancer.
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
IL192967A0 (en) Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
BRPI0818193A2 (pt) composto, sal farmacêuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto
BRPI0816553A2 (pt) "composto, composição farmcêutica, uso de uma composição, uso de um composto, e, processo para a preparação de um composto"
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
CL2007003470A1 (es) Compuestos derivados de urea; composicion farmaceutica que comprende a dichos compuestos; y su uso como antibacterianos.
BRPI0810161A2 (pt) Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto
BRPI0906576A2 (pt) Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer
BRPI0814666A2 (pt) composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
BRPI0907892A2 (pt) Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo
CL2007003232A1 (es) Compuestos derivados de 5-hidroximetil oxazolidin-2-ona; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar y prevenir infecciones bacterianas.
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
BRPI0814189A2 (pt) Ácido ribonucleico de filamento duplo, composição farmacêutica e seus usos, método para inibir a expressão de fosfatidilinositol 4-cinase, vetor e uso de um composto que seletivamente inibe a atividade da fosfatidilinositol 4-cinase.
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
BRPI0812942A2 (pt) Composto, composição farmacêutica e uso de um composto
CL2008000380A1 (es) Composicion farmaceutica que comprende un antagonista muscarinico y un antagonista beta 2-adrenoceptor; kit farmaceutico que comprende a dicha composicion farmaceutica; y su uso para tratar una enfermedad pulmonar obstructiva cronica.
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
BRPI0820985A2 (pt) Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
BRPI0810025A2 (pt) Formulação farmacêutica oral de liberação imediata, método para preparar uma formulação farmacêutica multiparticulada, e, uso de ácido ursodesoxicólico
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto